| Institution: | 1. Department of Innovative Medical Science, Tokai University School of Medicine, Isehara, Japan;2. Division of Hematological Malignancy, Institute of Medical Sciences, Tokai University, Isehara, Japan;3. Laboratory of Microenvironmental Metabolic Health Sciences Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan;4. Department of Pathology, Tokai University School of Medicine, Isehara, Japan;5. Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan;6. Support Center for Medical Research and Education, Tokai University School of Medicine, Isehara, Japan;7. Division of Bioscience and Bioindustry, Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima, Japan;8. Center for Cancer Immunology, Cutaneous Biology Research Center, Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA;9. Department of Pharmacy, Shiga University of Medical Science Hospital, Otsu, Japan;10. Department of Pharmaceutical Sciences, Tohoku University, Sendai, Japan;11. Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan |
